Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FT4RA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,370
Award facts
- Contract value 100% obligated
- $58,370.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $58,370.32 to AmerisourceBergen Drug Corp for the supply of Vyndamax 61 mg capsule in unit dose 30-count packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is scheduled for ultimate completion on January 5, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive vehicle for pharmaceutical procurement supporting military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies and medications to federal healthcare systems, particularly the Defense Health Agency, U.S. Coast Guard, and other government medical programs. The company's extensive portfolio under the DLA contract vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a prime contractor on the DLA Troop Support Medical contract, AmerisourceBergen operates through a flexible delivery order structure that enables responsive fulfillment of pharmaceutical needs. The DLA is concurrently planning the next generation of its Pharmaceutical Prime Vendor Global Program (Generation V) contracts, which will likely involve multiple awards across separate regions, indicating continued emphasis on competitive pharmaceutical sourcing for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FT4RA?
SPE2DR26FT4RA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FT4RA worth?
The government has obligated $58,370 on SPE2DR26FT4RA.
Is contract SPE2DR26FT4RA an order under another contract?
Yes. SPE2DR26FT4RA is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT4RA competed?
The extent of competition for SPE2DR26FT4RA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award